Secretory IgA–Gut Microbiota Crosstalk in Mucosal Immunity
Authors:
- Faisal S. AlagrafiFAFaisal S. Alagrafi
- Samiyah Al-KhaldiSASamiyah Al-Khaldi
- Mohammad N. AlkhrayefMAMohammad N. Alkhrayef
- Ibtihal S. AlduhaymiIAIbtihal S. Alduhaymi
- Musaad A. AltammamiMAMusaad A. Altammami
- Hala A. AlamariHAHala A. Alamari
- Monira AlshehriMAMonira Alshehri
- Hind J. AlthagafiHAHind J. Althagafi
- Hussam M. FallatahHFHussam M. Fallatah
- Essam J. AlyamaniEAEssam J. Alyamani
- Mohannad M. FallatahMFMohannad M. Fallatah
- Yahya F. JamousYahya F. Jamous
Open Access
- 13 November 2026
- journal article
- review article
- Published by MDPI AG in Biomedicines
- Vol. 14 (11) , 2618
Abstract
Secretory immunoglobulin A (SIgA) represents the most abundant antibody isotype at mucosal surfaces and plays a central role in maintaining intestinal immune homeostasis. In addition to its classical function in immune exclusion of pathogens, SIgA actively shapes the composition, spatial organization, and functional behavior of the gut microbiota, thereby contributing to a dynamic and reciprocal host–microbe relationship. Increasing evidence highlights that crosstalk between SIgA and the gut microbiota is not merely protective but also regulatory, influencing immune tolerance, barrier integrity, and inflammatory balance within the intestinal mucosa. This review provides a comprehensive overview of the molecular and immunological mechanisms underlying SIgA–microbiota interactions in mucosal immunity. We discuss the processes governing SIgA induction, class switching, and antigen specificity, as well as the mechanisms by which SIgA selectively coats commensal and pathogenic microorganisms. Emphasis is placed on how SIgA-mediated immune modulation shapes microbial ecology, limits immune overactivation, and maintains long-term mucosal homeostasis. Moreover, the review describes the role of dysregulation in SIgA–microbiota interactions in immune-mediated and inflammatory diseases, as well as the emerging translational perspectives. This includes the potential of SIgA-targeted strategies to modulate the gut microbiota for therapeutic benefit. By integrating mechanistic insights with clinical relevance, this review highlights SIgA–microbiota interactions at the intersection of mucosal immunology and emerging immunotherapeutic opportunities.Keywords
This publication has 145 references indexed in Scilit:
- Human Systems Immunology in the Omics Era: Challenges, Methods, and Emerging DirectionsEuropean Journal of Immunology, 2026
- Mouse IgA modulates human gut microbiota with inflammatory bowel disease patientsJournal of Gastroenterology, 2024
- Multiregion single‐cell sequencing reveals the transcriptional landscape of the immune microenvironment of colorectal cancerClinical and Translational Medicine, 2021
- Specific microbiota enhances intestinal IgA levels by inducing TGF‐β in T follicular helper cells of Peyer's patches in miceEuropean Journal of Immunology, 2020
- Multiplex determination of serological signatures in the sera of colorectal cancer patients using hydrogel biochipsCancer Medicine, 2016
- IgA EGFR antibodies mediate tumour killing in vivoEMBO Molecular Medicine, 2013
- Epithelial‐microbial crosstalk in polymeric Ig receptor deficient miceEuropean Journal of Immunology, 2012
- Selective IgA DeficiencyJournal of Clinical Immunology, 2010
- Structural Insights into Antibody-Mediated Mucosal Immunity2006
- The function of immunoglobulin A in immunityThe Journal of Pathology, 2005